These results indicate that a single-sensor, distribution-aware approach can provide a reliable acoustic surrogate for AHI and clinically relevant severity classification. The proposed wearable and CMAP model offer a practical, comfortable, and cost-effective solution for early clinical triaging, scalable home-based OSA screening and longitudinal monitoring with low user burden.
Song et al. (Fri,) studied this question.